P
PMV Pharmaceuticals D
D
PMVP
1.60000
USD
0.01
(0.63%)
Market Closed
Volume
4,398
EPS
-1
Div Yield
-
P/E
-2
Market Cap
82,795,408
Novo Nordisk Surges in Profit and Sales
6 months ago
Stocks news More
Title: PMV Pharmaceuticals
Sector: Healthcare
Industry: Biotechnology
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.